Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801931 · ClinicalTrials.gov registry record · Phase 1
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
A Phase 1 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00801931: Clinical Trial Phase 1 study, sponsored by Columbia University.
NCT00801931 is a Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00801931, a Phase 1 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and toxicity and feasibility of double umbilical cord blood transplantation (DUCBT) in patients with selected malignant and non-malignant, and to quantify the percentage and donor sources of mixed donor chimerism following DUCBT in patients with selected malignant and non-malignant disorders.
Primary Outcome
Number of patients to experience graft failure.
Interventions
- DRUG Melphalan
- DRUG Busulfan
- DRUG Alemtuzumab
- RADIATION Total Body Irradiation
- DRUG Phenytoin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-09-06 |
| Est. Completion | 2009-05-05 |
| Phase | Phase 1 |
Why NCT00801931 stopped before completion
NCT00801931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Melphalan is the first listed.
NCT00801931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00801931 about?
NCT00801931 is a clinical study titled "Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders". The purpose of this study is to determine the safety and toxicity and feasibility of double umbilical cord blood transplantation (DUCBT) in patients with selected malignant and non-malignant, and to quantify the percentage and donor sources of mixed donor chimerism following DUCBT in patients with s...
What is the current status of trial NCT00801931?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2007-09-06. Estimated completion is 2009-05-05.
What interventions are being tested in trial NCT00801931?
The interventions under investigation include: Melphalan (DRUG), Busulfan (DRUG), Alemtuzumab (DRUG), Total Body Irradiation (RADIATION), Phenytoin (DRUG).
Who is sponsoring clinical trial NCT00801931?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00801931's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI